ArticleOncoTargets and therapy2018

Downregulation of miR-638 promotes progression of breast cancer and is associated with prognosis of breast cancer patients.

Minghong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.